BIOMAT Database Logo BIOMAT Database Logo

Structure-activity relations for anticholinergic 2(1-aryl(or cyclohexyl)-1-hydroxy-1-phenyl)methyl-1,3-dioxolans. 1971

R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003510 Cyclohexanes Six-carbon alicyclic hydrocarbons.
D004149 Dioxoles
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012472 Salivation The discharge of saliva from the SALIVARY GLANDS that keeps the mouth tissues moist and aids in digestion.

Related Publications

R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams
Structure of (+/-)-(2S,1'S)-2-[hydroxy(phenyl)methyl]-2-methylcyclohexanone, C14H1802.
May 1991, Acta crystallographica. Section C, Crystal structure communications,
R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams
[Search for anticholinergic agents. VI. Synthesis of 5-substituted derivatives of 2-phenyl-2-methyldioxane-1,3,2-cyclohexyl-2-phenyldioxane-1,3 and 2,2-diphenyldioxane-1,3].
January 1978, Acta poloniae pharmaceutica,
R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams
Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides.
September 1988, Journal of medicinal chemistry,
R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams
Synthesis and structure-opioid activity relationships of trans-(+/-)-3,4-dichloro-N-methyl-N-[4- or 5-hydroxy-2-(1-pyrrolidiny)cyclohexyl]benzeneacetamides.
September 1997, The Journal of pharmacy and pharmacology,
R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams
[Bromination of 1-(1-hydroxy-2-oxo-cyclohexyl)-2-(2-oxo-cyclohexyl)-ethane].
June 1969, Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft,
R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams
Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane 3-oxide methiodides.
October 1989, Journal of medicinal chemistry,
R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams
Crystal structure of 1-[(1S,2R)-2-hydroxy-1-methyl-2-phenyl-eth-yl]pyrrolidinium 2-amino-5-chloro-benzoate.
August 2015, Acta crystallographica. Section E, Crystallographic communications,
R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams
Synthesis and pharmacological activity of 2-(substituted phenyl)-3-[2 or 3-[(4-substituted phenyl-4-hydroxy)piperidino]ethyl or propyl]-1,3-thiazolidin-4-ones.
April 1997, Farmaco (Societa chimica italiana : 1989),
R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams
Determination of structure-activity relationships of 2-aryl-1,3-indandiones.
March 1976, Il Farmaco; edizione scientifica,
R W Brimblecombe, and T D Inch, and J Wetherell, and N Williams
Synthesis and thromboxane A2 antagonistic activity of [[1-aryl(or benzyl)-1-(benzenesulfonamido)methyl]phenyl]alkanoic acid derivatives.
April 1996, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!